NFKB1 and neoplasm: Activation of NF-κB upregulates cyclin D1 [61] thus promoting cell cycle transition and anti-apoptotic genes, i.e., cIAP1, cIAP2, XIAP, Bcl-2 and Bcl-XL, providing tumour cells with survival advantages [57,61].